I agree it will be more of the same post UK approval too. The new excuse could be we are not approved in US, Canada, and EU, so we cant say much in those jurisdictions.
They said the same thing during the extended quiet period between data lock and TLD and JAMA that those events will end the quiet period and that there will be flurry of news and awareness building campaigns. 2.5 years later (after TLD), nothing has changed expect we lost another 70-80% in valuation.
Market Data 
Markets 
AI
